Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2022

Conditions
Short Bowel SyndromeIntestinal Failure
Interventions
DRUG

Teduglutide

Intervention group consists of patients, who receive teduglutide within routine medical care

Trial Locations (1)

10117

RECRUITING

Charite University, Berlin, Germany, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER